FDA Inspection 961061 — Biomat USA, Inc
The FDA completed an inspection of Biomat USA, Inc on March 4, 2016 in Fayetteville, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 4, 2016
- Fiscal Year
- 2016
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Fayetteville, NC (United States)